These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 26055355)

  • 1. Anaemia in kidney disease: harnessing hypoxia responses for therapy.
    Koury MJ; Haase VH
    Nat Rev Nephrol; 2015 Jul; 11(7):394-410. PubMed ID: 26055355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease.
    Kaplan JM; Sharma N; Dikdan S
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29382128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factors link iron homeostasis and erythropoiesis.
    Shah YM; Xie L
    Gastroenterology; 2014 Mar; 146(3):630-42. PubMed ID: 24389303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiology and pathophysiology of renal erythropoietin-producing cells.
    Shih HM; Wu CJ; Lin SL
    J Formos Med Assoc; 2018 Nov; 117(11):955-963. PubMed ID: 29655605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New insights in the pathophysiology and treatment of renal anemia].
    Vultaggio P; Loria F; Fakhouri F; Leuenberger N; Pruijm M
    Rev Med Suisse; 2022 Mar; 18(771):358-363. PubMed ID: 35235258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of erythropoiesis by hypoxia-inducible factors.
    Haase VH
    Blood Rev; 2013 Jan; 27(1):41-53. PubMed ID: 23291219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease.
    Solak Y; Cetiner M; Siriopol D; Tarim K; Afsar B; Covic A; Kanbay M
    Blood Purif; 2016; 42(2):160-7. PubMed ID: 27318465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease.
    Sugahara M; Tanaka T; Nangaku M
    Kidney Int; 2017 Aug; 92(2):306-312. PubMed ID: 28651951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease.
    Del Vecchio L; Locatelli F
    Expert Opin Investig Drugs; 2018 Jul; 27(7):613-621. PubMed ID: 29975110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis.
    Watts D; Gaete D; Rodriguez D; Hoogewijs D; Rauner M; Sormendi S; Wielockx B
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.
    Maxwell PH; Eckardt KU
    Nat Rev Nephrol; 2016 Mar; 12(3):157-68. PubMed ID: 26656456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationships among gut microbiota, hypoxia-inducible factor and anaemia with chronic kidney disease.
    Liu L; Xu W; Kong P; Dou Y
    Nephrology (Carlton); 2022 Nov; 27(11):851-858. PubMed ID: 35603584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.
    Kapitsinou PP; Liu Q; Unger TL; Rha J; Davidoff O; Keith B; Epstein JA; Moores SL; Erickson-Miller CL; Haase VH
    Blood; 2010 Oct; 116(16):3039-48. PubMed ID: 20628150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hypoxia in progressive chronic kidney disease and implications for therapy.
    Shoji K; Tanaka T; Nangaku M
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):161-8. PubMed ID: 24378776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia in CKD-treatment standard.
    Macdougall IC
    Nephrol Dial Transplant; 2024 Apr; 39(5):770-777. PubMed ID: 38012124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia. 5. Hypoxia and hematopoiesis.
    Yoon D; Ponka P; Prchal JT
    Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1215-22. PubMed ID: 21368293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease.
    Hasegawa S; Tanaka T; Nangaku M
    Curr Opin Nephrol Hypertens; 2018 Sep; 27(5):331-338. PubMed ID: 30067604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic regulation of erythropoiesis and iron metabolism.
    Haase VH
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F1-13. PubMed ID: 20444740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation.
    Icardi A; Paoletti E; De Nicola L; Mazzaferro S; Russo R; Cozzolino M
    Nephrol Dial Transplant; 2013 Jul; 28(7):1672-9. PubMed ID: 23468534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patients.
    Nangaku M; Mimura I; Yamaguchi J; Higashijima Y; Wada T; Tanaka T
    J Ren Nutr; 2015 Mar; 25(2):160-3. PubMed ID: 25556149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.